Home / Companies / Eurofins BioPharma Product Testing Sweden AB

Eurofins BioPharma Product Testing Sweden AB FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection VAI · Jun 19, 2024
No warning letters matched by name

Inspections 9

0 OAI

Recalls 0 0 Class I

Warning letters 0 None on file

510(k) clearances 0 None on file

Eurofins BioPharma Product Testing Sweden AB has 0 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Eurofins BioPharma Product Testing Sweden AB" is on file.

What these totals cover: FDA records filed under the name "Eurofins BioPharma Product Testing Sweden AB" and its spelling variant "Eurofins Biopharma Product Testing Sweden".

Latest inspection: Jun 19, 2024 · VAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	9	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Eurofins BioPharma Product Testing Sweden AB's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Eurofins BioPharma Product Testing Sweden AB: FDA inspections per year

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	0	0	0	0	0
2024	2	0	0	0	0
2023	0	0	0	0	0
2022	1	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	0	0	0	0	0
2017	1	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Eurofins BioPharma Product Testing Sweden AB as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Eurofins BioPharma Product Testing Sweden AB yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

9 inspections from Feb 16, 2011 to Jun 19, 2024.

Date	Site	Product	Classification	FEI
Jun 19, 2024	Uppsala, Sweden	Drugs	Voluntary Action Indicated (VAI)	3008759559
Jun 19, 2024	Uppsala, Sweden	Drugs	Voluntary Action Indicated (VAI)	3008763211
Dec 8, 2022	Uppsala, Sweden	Drugs	Voluntary Action Indicated (VAI)	3008763211
Jun 27, 2019	Uppsala, Sweden	Drugs	No Action Indicated (NAI)	3008759559
May 12, 2017	Uppsala, Sweden	Drugs	No Action Indicated (NAI)	3008763211
Mar 13, 2015	Uppsala, Sweden	Veterinary	Voluntary Action Indicated (VAI)	3008763211
Mar 9, 2015	Uppsala, Sweden	Veterinary	No Action Indicated (NAI)	3008759559
Feb 18, 2011	Uppsala, Sweden	Veterinary	Voluntary Action Indicated (VAI)	3008763211
Feb 16, 2011	Uppsala, Sweden	Veterinary	Voluntary Action Indicated (VAI)	3008759559

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3008759559	Uppsala, Sweden	4	Jun 19, 2024
FEI 3008763211	Uppsala, Sweden	5	Jun 19, 2024

Eurofins BioPharma Product Testing Sweden AB and the FDA: common questions

Has Eurofins BioPharma Product Testing Sweden AB received an FDA warning letter?

No FDA warning letter addressed to the name "Eurofins BioPharma Product Testing Sweden AB" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Eurofins BioPharma Product Testing Sweden AB received an FDA Form 483?

FDA has not published a Form 483 for "Eurofins BioPharma Product Testing Sweden AB" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Eurofins BioPharma Product Testing Sweden AB?

The most recent FDA inspection on file ended Jun 19, 2024 at Uppsala, Sweden and was classified VAI. FDA has 9 inspections of Eurofins BioPharma Product Testing Sweden AB on file.

Need more than this page shows? Ask about Eurofins BioPharma Product Testing Sweden AB in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.